GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Short-Term Debt

Replek AD (XMAE:REPL) Short-Term Debt : MKD0 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Replek AD Short-Term Debt?

Replek AD's Short-Term Debt for the quarter that ended in Sep. 2024 was MKD0 Mil.

Replek AD's quarterly Short-Term Debt increased from Dec. 2023 (MKD168 Mil) to Jun. 2024 (MKD217 Mil) but then declined from Jun. 2024 (MKD217 Mil) to Sep. 2024 (MKD0 Mil).

Replek AD's annual Short-Term Debt increased from Dec. 2021 (MKD48 Mil) to Dec. 2022 (MKD159 Mil) and increased from Dec. 2022 (MKD159 Mil) to Dec. 2023 (MKD168 Mil).

Replek AD Short-Term Debt Historical Data

The historical data trend for Replek AD's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Short-Term Debt Chart

Replek AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.17 87.37 48.20 159.41 168.44

Replek AD Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 168.44 - 168.44 217.14 -

Replek AD Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Replek AD Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Replek AD's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Replek AD Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Short-Term Debt
Comparable Companies
XMAE:GRNT XMAE:MTUR XMAE:VITA XMAE:TEL XMAE:TETE XMAE:ALK XMAE:STIL XMAE:TNB XMAE:KMB ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Website
https://www.replek.mk
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.